Latest topics page 25
Topics ordered by most recent activity across all 71 subcategories.
1,535 topics · page 25 of 52
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Older adults, sarcopenia risk, and the trade-off nobody quantifies
Older adults, sarcopenia risk, and the trade-off nobody quantifies — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published…
|
+103 | 109 | 12k | 5mo |
|
Non-inferiority margins: how they are chosen and how they are abused — a second dataset
Non-inferiority margins: how they are chosen and how they are abused — a second dataset — setting out what I have, and where I think it stops being reliable. Comparing FLOW ( N Engl J Med , 2024) with…
|
+32 | 37 | 574 | 5mo |
|
Cardiovascular risk: reading the outcome trials as a set
Cardiovascular risk: reading the outcome trials as a set Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
|
4 | 12k | 5mo | |
|
Anxiety in the first weeks: drug, situation, or both — what changed since
Anxiety in the first weeks: drug, situation, or both — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a…
|
+88 | 95 | 4.5k | 5mo |
|
Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on
Asking directly, because I could not find a straight answer: Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Working through the identity arithmetic and I would like it…
|
+10 | 14 | 13k | 5mo |
|
Revisiting: What SELECT changed about how semaglutide is discussed, and what it did not
Revisiting: What SELECT changed about how semaglutide is discussed, and what it did not Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURMOUNT-OSA ( N Engl J…
|
2 | 1.9k | 5mo | |
|
An ABAB design with a data table and honest limitations
An ABAB design with a data table and honest limitations Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURPASS-4 ( Lancet , 2021). Please read it before…
|
2 | 45k | 5mo | |
|
[2026 update] Reading a supplementary appendix and finding the interesting part
On the subject in the title: Reading a supplementary appendix and finding the interesting part Working notes rather than a conclusion. Comparing SELECT ( N Engl J Med , 2023) with FLOW ( N Engl J Med , 2024)…
|
+39 | 44 | 8.2k | 5mo |
|
Why "dose equivalence" between different incretin analogues is a weak concept
Why "dose equivalence" between different incretin analogues is a weak concept I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on this…
|
+124 | 133 | 11k | 5mo |
|
[2026 update] A rising related-substance total over six months: degradation or method drift?
The question in the title: A rising related-substance total over six months: degradation or method drift? I will give what I have already checked below so nobody repeats it. Posting the method first, because…
|
+71 | 78 | 34k | 5mo |
|
Revisiting: Absolute versus relative contraindications
Revisiting: Absolute versus relative contraindications Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
|
+11 | 15 | 22k | 5mo |
|
Seven-day rolling means and why weekly readings mislead — one year on
On the subject in the title: Seven-day rolling means and why weekly readings mislead — one year on Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without…
|
+78 | 88 | 16k | 5mo |
|
Tag proliferation and whether we should prune — what changed since
Tag proliferation and whether we should prune — what changed since — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation commons. The…
|
+5 | 9 | 709 | 5mo |
|
Mass error in ppm: the arithmetic and the caveat
Mass error in ppm: the arithmetic and the caveat Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like it checked.…
|
+108 | 125 | 1.5k | 5mo |
|
[2026 update] Long-time reader, first-time poster
Long-time reader, first-time poster — setting out what I have, and where I think it stops being reliable. Lower-stakes topic, but the sourcing rule still applies if anyone makes a claim. Something adjacent…
|
+46 | 50 | 23k | 5mo |
|
Non-inferiority margins: how they are chosen and how they are abused
Posting this under the heading it deserves: Non-inferiority margins: how they are chosen and how they are abused Everything below is what sits behind that. Comparing SURPASS-2 ( N Engl J Med , 2021) with…
|
+42 | 46 | 10k | 5mo |
|
Coverage in the US: a map of the usual obstacles
Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the…
|
+46 | 50 | 7.9k | 5mo |
|
Storing in the door of the fridge is worse than you think
Storing in the door of the fridge is worse than you think Writing it up because I had to work it out twice and would rather nobody else did. A question about technique rather than about dose. I have been…
|
2 | 8.3k | 5mo | |
|
What I would record differently if I started again — the long version
What I would record differently if I started again — the long version I have a specific reason for asking rather than idle curiosity, and the context is below. Maintenance rather than loss, which is the part…
|
+22 | 26 | 57k | 5mo |
|
Filter needles: when they help and what they cost you
On the subject in the title: Filter needles: when they help and what they cost you Working notes rather than a conclusion. A question about technique rather than about dose. I have been doing the same thing…
|
+45 | 50 | 19k | 5mo |
|
Trifluoroacetate content and its consequences
Trifluoroacetate content and its consequences — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate in front of me…
|
+123 | 134 | 31k | 5mo |
|
Adsorption to container surfaces and to plastics
On the subject in the title: Adsorption to container surfaces and to plastics Working notes rather than a conclusion. A documentation question rather than an analytical one. I have a certificate in front of…
|
+13 | 17 | 4.3k | 5mo |
|
Revisiting: Review: an evidence digest and the citation check that delayed it
Revisiting: Review: an evidence digest and the citation check that delayed it — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation…
|
+54 | 58 | 8.2k | 5mo |
|
Coming back to: Pen dose counters: what a click does and does not guarantee
Pen dose counters: what a click does and does not guarantee — setting out what I have, and where I think it stops being reliable. A question about technique rather than about dose. I have been doing the same…
|
4 | 105 | 5mo | |
|
Can a home kit substitute for a laboratory report? A careful no
Asking directly, because I could not find a straight answer: Can a home kit substitute for a laboratory report? A careful no I would like to understand what this number means before I repeat it anywhere. A…
|
+122 | 131 | 1.7k | 5mo |
|
Heterogeneity as information rather than as a nuisance
Posting this under the heading it deserves: Heterogeneity as information rather than as a nuisance Everything below is what sits behind that. Session topic: SCALE ( N Engl J Med , 2015). Please read it before…
|
+88 | 95 | 1.2k | 6mo |
|
Distinguishing a red flag from an inconvenience
Distinguishing a red flag from an inconvenience — setting out what I have, and where I think it stops being reliable. I would like to talk about documentation quality as a signal, separately from product…
|
2 | 38k | 6mo | |
|
Coming back to: Reconstitution volumes that produce round numbers, tabulated
On the subject in the title: Reconstitution volumes that produce round numbers, tabulated Working notes rather than a conclusion. Practical question with the units stated, because I have seen how quickly…
|
2 | 24k | 6mo | |
|
Follow-up: A supplier that answers analytical questions with restated claims
A supplier that answers analytical questions with restated claims — setting out what I have, and where I think it stops being reliable. A logistics question, since the answers here are usually better than…
|
+74 | 82 | 2.8k | 6mo |
|
When to stop reading forums, including this one
When to stop reading forums, including this one I have a specific reason for asking rather than idle curiosity, and the context is below. General question, not a request for advice about my own care — I know…
|
+78 | 86 | 47k | 6mo |